NUVB
Nuvation Bio·NYSE
--
--(--)
--
--(--)
NUVB fundamentals
Nuvation Bio (NUVB) released its earnings on Nov 3, 2025: revenue was 13.12M (YoY +1774.29%), beat estimates; EPS was -0.16 (YoY -6.67%), missed estimates.
Revenue / YoY
13.12M
+1774.29%
EPS / YoY
-0.16
-6.67%
Report date
Nov 3, 2025
NUVB Earnings Call Summary for Q3,2025
- IBTROZI Launch Success: 204 new patients in Q3 (15/week), 50-month DOR in TKI-naive patients, surpassing competitor performance.
- Financial Strength: $13.1M Q3 revenue, $549M cash, no guidance but $55M annualized run rate from Q3 patients.
- Strategic Wins: Japan approval with $25M milestone, advanced Europe partnership, avoided $100M study cost.
- Pipeline Momentum: TRUST-IV adjuvant trial initiated, safusidenib high-grade glioma trial on track, NUV-1511 data pending.
- Market Leadership: 80% payer coverage, 98% territory engagement, fastest ROS1 launch in history.
EPS
Revenue
Revenue & Expenses
NUVB has released its 2025 Q3 earnings report, with revenue of 13.12M, reflecting a YoY change of 1704.68%, and net profit of -55.79M, showing a YoY change of -35.38%. The Sankey diagram below clearly presents NUVB's revenue sources and cost distribution.
Key Indicators
Nuvation Bio (NUVB) key financial stats and ratios, covering profitability, financial health, and leverage.
Nuvation Bio (NUVB)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Nuvation Bio (NUVB)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Nuvation Bio (NUVB)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Nuvation Bio (NUVB) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Nuvation Bio (NUVB) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Nuvation Bio’s earnings call?Did Nuvation Bio beat or miss consensus estimates last quarter?What is the market's earnings forecast for Nuvation Bio next quarter?What is Nuvation Bio's gross profit margin?What is Nuvation Bio's latest dividend and current dividend yield?What guidance did Nuvation Bio's management provide for the next earnings period?What is the revenue and EPS growth rate for Nuvation Bio year over year?What factors drove the changes in Nuvation Bio's revenue and profit?
